Interfant-99 protocol Outcome of congenital acute lymphoblastic leukemia treated on the

[1]  R. Pieters,et al.  A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial , 2007, The Lancet.

[2]  N. Heerema,et al.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. , 2006, Blood.

[3]  C. Pui,et al.  Treatment of acute lymphoblastic leukemia. , 2006, The New England journal of medicine.

[4]  G. Henze,et al.  Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials , 2005, Leukemia.

[5]  A. Veerman,et al.  Congenital leukaemia: the Dutch experience and review of the literature , 2002, British journal of haematology.

[6]  S. Richards,et al.  Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999 , 2002, British journal of haematology.

[7]  C. Pui,et al.  Biological and therapeutic aspects of infant leukemia. , 2000, Blood.

[8]  A. Borkhardt,et al.  Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. , 1999, Blood.

[9]  N. Heerema,et al.  Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. D. Boer,et al.  Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants , 1998, Leukemia.

[11]  J. Shuster,et al.  Intensive Alternating Drug Pairs After Remission Induction for Treatment of Infants With Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Pilot Study , 1998, Journal of pediatric hematology/oncology.

[12]  R. Gelber,et al.  Intensified therapy for infants with acute lymphoblastic leukemia , 1997, Cancer.

[13]  M. Greaves,et al.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Hiddemann,et al.  Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. , 1994, Blood.

[15]  Y. Bertrand,et al.  Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group , 1994, British journal of haematology.

[16]  M. Valsecchi,et al.  Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. , 2006, Haematologica.

[17]  R. Pieters.  Biology and Treatment of Infant Leukemias , 2003 .

[18]  L. Frankel,et al.  Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). , 1997, Journal of pediatric hematology/oncology.

[19]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .